Skip to main content
Swing Capital

JHS Svendgaard Laboratories Ltd

NSE: JHS BSE: 532771

Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of oral and dental products for national and international brands[1]

₹8.79
52W: ₹6.15 — ₹15.5
PE 0 · Book ₹20.3 · -57% vs book
Market Cap₹76.8 Cr
Stock P/E—Price to Earnings
ROCE5.17%Return on Capital
ROE10.8%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company is almost debt free.
  • +Stock is trading at 0.42 times its book value
  • +Debtor days have improved from 66.0 to 51.8 days.

Weaknesses

  • −Company has low interest coverage ratio.
  • −Promoter holding has decreased over last quarter: -0.71%
  • −The company has delivered a poor sales growth of -7.10% over past five years.
  • −Promoter holding is low: 33.8%
  • −Company has a low return on equity of -4.10% over last 3 years.
  • −Earnings include an other income of Rs.1.29 Cr.

Shareholding Pattern

Promoters33.85%
FIIs3.6%
DIIs0%
Public62.57%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters37.73%34.56%▼3.234.56%34.56%34.56%34.56%34.56%33.85%▼0.7
FIIs0.15%1.69%▲1.51.59%▼0.11.6%▲0.01.59%▼0.01.57%▼0.01.57%3.6%▲2.0
DIIs6.05%0%▼6.00%0%0%0%0%0%
Public56.05%63.76%▲7.763.85%▲0.163.84%▼0.063.86%▲0.063.87%▲0.063.86%▼0.062.57%▼1.3

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales18.9314.321.6624.4819.6822.6625.1723.4522.2823.27
Expenses18.5214.3520.8222.5120.5222.4130.5521.7921.3721.6
Operating Profit0.41-0.050.841.97-0.840.25-5.381.660.911.67
OPM %2.17%-0.35%3.88%8.05%-4.27%1.1%-21.37%7.08%4.08%7.18%
Net Profit-0.730.01-0.75-0.63-10.32-1.84-6.961.06-0.20.79
EPS ₹-0.090-0.1-0.08-1.21-0.21-0.810.12-0.020.09

AI Insights

Revenue Trend

TTM revenue at ₹94.17Cr, up 2.4% YoY. OPM at -1.21%.

Debt Position

Borrowings at ₹10.59Cr. Debt-to-equity ratio: 0.12x. Healthy balance sheet.

Capex Cycle

CWIP at ₹2.95Cr (3% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 3.6% (+3.60pp change). Promoters hold 33.85%.

Margin & Efficiency

ROCE improving from -10.68% (Mar 2014) to -5.17% (Mar 2025). Working capital days: 48.44.

Recent Announcements